Minapharm Pharmaceuticals posts 96% profit leap in H1-21

Cairo – Mubasher: Minapharm Pharmaceuticals recorded a 96.47% year-on-year (YoY) hike in its consolidated net profits attributable to the company's owners, logging EGP 255.63 million in the first half (H1) of 2021, compared to EGP 130.11 million.

The revenues increased to EGP 1.45 billion in the six-month period ended 30 June from EGP 1.06 billion in the corresponding period in 2020, the company said in a bourse disclosure on Monday.

During the first quarter (Q1) of 2021, the company posted consolidated net profits after tax, including minority rights, worth EGP 121.9 million, compared to EGP 79.24 million in the year-ago period.

Source: Mubasher

Disclaimer: The content of this article is syndicated or provided to this website from an external third party provider. We are not responsible for, and do not control, such external websites, entities, applications or media publishers. The body of the text is provided on an “as is” and “as available” basis and has not been edited in any way. Neither we nor our affiliates guarantee the accuracy of or endorse the views or opinions expressed in this article. Read our full disclaimer policy here.